NCT00158093: A Safety Evaluation of ECG Intervals and Blood Pressure in Normal Healthy Volunteers After Use of Nebivolol, Atenolol, Moxifloxacin, or Placebo |
|
|
| Completed | 1 | 260 | US | Nebivolol, Atenolol, Moxifloxacin | Mylan Bertek Pharmaceuticals | Hypertension | | 07/03 | | |
NCT01358409: Regression of Myocardial Steatosis by Nebivolol |
|
|
| Completed | 1 | 31 | US | Nebivolol, Bystolic® by Forest/Mylan | Lidia Szczepaniak, Forest Laboratories | Cardiac Steatosis and Lipotoxicity | 02/13 | 02/13 | | |
NCT00223717: Treatment of Supine Hypertension in Autonomic Failure |
|
|
| Completed | 1 | 152 | US | Clonidine, Catapres, Nitroglycerin transdermal, Nitro-Dur, Dipyridamole/ Aspirin (Aggrenox), Aggrenox, Desmopressin (DDAVP), DDAVP, Sildenafil, Viagra, Nifedipine, Adalat, Hydralazine, Hydrochlorothiazide, Microzide, Placebo, Bosentan, Tracleer, Diltiazem, Cardizem, Eplerenone, Inspra, guanfacine, Tenex, L-arginine, captopril, capoten, carbidopa, Lodosyn, losartan, cozaar, metoprolol tartrate, lopressor, nebivolol hydrochloride, Bystolic, prazosin hydrochloride, Minipress, tamsulosin hydrochloride, Flomax, Head-up tilt., HUT, aliskiren, Tekturna, Local heat stress, heating pad | Vanderbilt University | Hypertension | 01/17 | 01/17 | | |
NCT04888728: To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers |
|
|
| Completed | 1 | 24 | RoW | DWN12088, Nebivolol, Paroxetine | Daewoong Pharmaceutical Co. LTD. | Idiopathic Pulmonary Fibrosis | 07/21 | 07/21 | | |